Six-month humoral response to BNT162b2 mRNA COVID-19 vaccine in people with multiple sclerosis treated with natalizumab |
| |
| Authors: | Altieri,Manuela,Capuano,Rocco,Conte,Miriana,Donnarumma,Giovanna,Grimaldi,Elena,Coppola,Nicola,Galdiero,Massimiliano,d&# Ambrosio,Alessandro,Tedeschi,Gioacchino,Gallo,Antonio |
| |
| Affiliation: | Altieri,Manuela,Capuano,Rocco,Conte,Miriana,Donnarumma,Giovanna,Grimaldi,Elena,Coppola,Nicola,Galdiero,Massimiliano,d’Ambrosio,Alessandro,Tedeschi,Gioacchino,Gallo,Antonio |
| |
| Abstract: | ![]()
Neurological Sciences - Few studies investigated the immune response to SARS-CoV-2 vaccine in patients with multiple sclerosis (pwMS) treated with natalizumab (NTZ) and found a short-term efficient... |
| |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ |
|
